[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

China Erectile Dysfunction Drugs Market Research Report 2018

March 2018 | 99 pages | ID: C26111F0380EN
QYResearch

US$ 3,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Erectile Dysfunction Drugs market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Erectile Dysfunction Drugs development status and future trend in China, focuses on top players in China, also splits Erectile Dysfunction Drugs by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
  • Pfizer
  • Eli Lilly
  • Bayer
  • Johnson & Johnson
  • Apricus Biosciences
  • Dong-A Pharmaceutical
Geographically, this report splits the China market into six regions,
  • South China
  • East China
  • Southwest China
  • Northeast China
  • North China
  • Central China
  • Northwest China
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
  • Phosphodiestarse - 5 Inhibitors (PDE5I)
  • Alprostadil
  • Testosterone
  • Others
On the basis of the end users/application, this report covers
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
If you have any special requirements, please let us know and we will offer you the report as you want.
China Erectile Dysfunction Drugs Market Research Report 2018

1 ERECTILE DYSFUNCTION DRUGS OVERVIEW

1.1 Product Overview and Scope of Erectile Dysfunction Drugs
1.2 Classification of Erectile Dysfunction Drugs by Product Category
  1.2.1 China Erectile Dysfunction Drugs Sales (K Units) Comparison by Type (2013-2025)
  1.2.2 China Erectile Dysfunction Drugs Sales (K Units) Market Share by Type in 2017
  1.2.3 Phosphodiestarse - 5 Inhibitors (PDE5I)
  1.2.4 Alprostadil
  1.2.5 Testosterone
  1.2.6 Others
1.3 China Erectile Dysfunction Drugs Market by Application/End Users
  1.3.1 China Erectile Dysfunction Drugs Sales (K Units) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Hospital Pharmacies
  1.3.3 Retail Pharmacies
  1.3.4 Online Pharmacies
1.4 China Erectile Dysfunction Drugs Market by Region
  1.4.1 China Erectile Dysfunction Drugs Market Size (Million USD) Comparison by Region (2013-2025)
  1.4.2 South China Erectile Dysfunction Drugs Status and Prospect (2013-2025)
  1.4.3 East China Erectile Dysfunction Drugs Status and Prospect (2013-2025)
  1.4.4 Southwest China Erectile Dysfunction Drugs Status and Prospect (2013-2025)
  1.4.5 Northeast China Erectile Dysfunction Drugs Status and Prospect (2013-2025)
  1.4.6 North China Erectile Dysfunction Drugs Status and Prospect (2013-2025)
  1.4.7 Central China Erectile Dysfunction Drugs Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Erectile Dysfunction Drugs (2013-2025)
  1.5.1 China Erectile Dysfunction Drugs Sales (K Units) and Growth Rate (%)(2013-2025)
  1.5.2 China Erectile Dysfunction Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 CHINA ERECTILE DYSFUNCTION DRUGS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Erectile Dysfunction Drugs Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Erectile Dysfunction Drugs Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Erectile Dysfunction Drugs Average Price (USD/Unit) by Players/Manufacturers (2013-2018)
2.4 China Erectile Dysfunction Drugs Market Competitive Situation and Trends
  2.4.1 China Erectile Dysfunction Drugs Market Concentration Rate
  2.4.2 China Erectile Dysfunction Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Erectile Dysfunction Drugs Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA ERECTILE DYSFUNCTION DRUGS SALES AND REVENUE BY REGION (2013-2018)

3.1 China Erectile Dysfunction Drugs Sales (K Units) and Market Share by Region (2013-2018)
3.2 China Erectile Dysfunction Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Erectile Dysfunction Drugs Price (USD/Unit) by Regions (2013-2018)

4 CHINA ERECTILE DYSFUNCTION DRUGS SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2013-2018)

4.1 China Erectile Dysfunction Drugs Sales (K Units) and Market Share by Type/ Product Category (2013-2018)
4.2 China Erectile Dysfunction Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Erectile Dysfunction Drugs Price (USD/Unit) by Type (2013-2018)
4.4 China Erectile Dysfunction Drugs Sales Growth Rate (%) by Type (2013-2018)

5 CHINA ERECTILE DYSFUNCTION DRUGS SALES BY APPLICATION (2013-2018)

5.1 China Erectile Dysfunction Drugs Sales (K Units) and Market Share by Application (2013-2018)
5.2 China Erectile Dysfunction Drugs Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 CHINA ERECTILE DYSFUNCTION DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Erectile Dysfunction Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Erectile Dysfunction Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Eli Lilly
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Erectile Dysfunction Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Eli Lilly Erectile Dysfunction Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Bayer
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Erectile Dysfunction Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bayer Erectile Dysfunction Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Johnson & Johnson
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Erectile Dysfunction Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Johnson & Johnson Erectile Dysfunction Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Apricus Biosciences
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Erectile Dysfunction Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Apricus Biosciences Erectile Dysfunction Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Dong-A Pharmaceutical
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Erectile Dysfunction Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Dong-A Pharmaceutical Erectile Dysfunction Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.6.4 Main Business/Business Overview

7 ERECTILE DYSFUNCTION DRUGS MANUFACTURING COST ANALYSIS

7.1 Erectile Dysfunction Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Erectile Dysfunction Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Erectile Dysfunction Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Erectile Dysfunction Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA ERECTILE DYSFUNCTION DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

11.1 China Erectile Dysfunction Drugs Sales (K Units), Revenue (Million USD) Forecast (2018-2025)
11.2 China Erectile Dysfunction Drugs Sales (K Units) Forecast by Type (2018-2025)
11.3 China Erectile Dysfunction Drugs Sales (K Units) Forecast by Application (2018-2025)
11.4 China Erectile Dysfunction Drugs Sales (K Units) Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Erectile Dysfunction Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Erectile Dysfunction Drugs Sales (K Units) by Application (2013-2025)
Figure Product Picture of Erectile Dysfunction Drugs
Table China Erectile Dysfunction Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Erectile Dysfunction Drugs Sales Volume Market Share by Types in 2017
Figure Phosphodiestarse - 5 Inhibitors (PDE5I) Product Picture
Figure Alprostadil Product Picture
Figure Testosterone Product Picture
Figure Others Product Picture
Figure China Erectile Dysfunction Drugs Sales (K Units) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Erectile Dysfunction Drugs by Application in 2017
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure South China Erectile Dysfunction Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Erectile Dysfunction Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Erectile Dysfunction Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Erectile Dysfunction Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Erectile Dysfunction Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Erectile Dysfunction Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Erectile Dysfunction Drugs Sales (K Units) and Growth Rate (%)(2013-2025)
Figure China Erectile Dysfunction Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Erectile Dysfunction Drugs Sales of Key Players/Manufacturers (2013-2018)
Table China Erectile Dysfunction Drugs Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Erectile Dysfunction Drugs Sales Share (%) by Players/Manufacturers
Figure 2017 China Erectile Dysfunction Drugs Sales Share (%) by Players/Manufacturers
Table China Erectile Dysfunction Drugs Revenue by Players/Manufacturers (2013-2018)
Table China Erectile Dysfunction Drugs Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Erectile Dysfunction Drugs Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Erectile Dysfunction Drugs Revenue Market Share (%) by Players/Manufacturers
Table China Market Erectile Dysfunction Drugs Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Erectile Dysfunction Drugs Average Price of Key Players/Manufacturers in 2017
Figure China Erectile Dysfunction Drugs Market Share of Top 3 Players/Manufacturers
Figure China Erectile Dysfunction Drugs Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Erectile Dysfunction Drugs Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Erectile Dysfunction Drugs Product Category
Table China Erectile Dysfunction Drugs Sales (K Units) by Regions (2013-2018)
Table China Erectile Dysfunction Drugs Sales Share (%) by Regions (2013-2018)
Figure China Erectile Dysfunction Drugs Sales Share (%) by Regions (2013-2018)
Figure China Erectile Dysfunction Drugs Sales Market Share (%) by Regions in 2017
Table China Erectile Dysfunction Drugs Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Erectile Dysfunction Drugs Revenue Market Share (%) by Regions (2013-2018)
Figure China Erectile Dysfunction Drugs Revenue Market Share (%) by Regions (2013-2018)
Figure China Erectile Dysfunction Drugs Revenue Market Share (%) by Regions in 2017
Table China Erectile Dysfunction Drugs Price (USD/Unit) by Regions (2013-2018)
Table China Erectile Dysfunction Drugs Sales (K Units) by Type (2013-2018)
Table China Erectile Dysfunction Drugs Sales Share (%) by Type (2013-2018)
Figure China Erectile Dysfunction Drugs Sales Share (%) by Type (2013-2018)
Figure China Erectile Dysfunction Drugs Sales Market Share (%) by Type in 2017
Table China Erectile Dysfunction Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Erectile Dysfunction Drugs Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Erectile Dysfunction Drugs by Type (2013-2018)
Figure Revenue Market Share of Erectile Dysfunction Drugs by Type in 2017
Table China Erectile Dysfunction Drugs Price (USD/Unit) by Types (2013-2018)
Figure China Erectile Dysfunction Drugs Sales Growth Rate (%) by Type (2013-2018)
Table China Erectile Dysfunction Drugs Sales (K Units) by Applications (2013-2018)
Table China Erectile Dysfunction Drugs Sales Market Share (%) by Applications (2013-2018)
Figure China Erectile Dysfunction Drugs Sales Market Share (%) by Application (2013-2018)
Figure China Erectile Dysfunction Drugs Sales Market Share (%) by Application in 2017
Table China Erectile Dysfunction Drugs Sales Growth Rate (%) by Application (2013-2018)
Figure China Erectile Dysfunction Drugs Sales Growth Rate (%) by Application (2013-2018)
Table Pfizer Erectile Dysfunction Drugs Basic Information List
Table Pfizer Erectile Dysfunction Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Pfizer Erectile Dysfunction Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Pfizer Erectile Dysfunction Drugs Sales Market Share (%) in China (2013-2018)
Figure Pfizer Erectile Dysfunction Drugs Revenue Market Share (%) in China (2013-2018)
Table Eli Lilly Erectile Dysfunction Drugs Basic Information List
Table Eli Lilly Erectile Dysfunction Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Eli Lilly Erectile Dysfunction Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Eli Lilly Erectile Dysfunction Drugs Sales Market Share (%) in China (2013-2018)
Figure Eli Lilly Erectile Dysfunction Drugs Revenue Market Share (%) in China (2013-2018)
Table Bayer Erectile Dysfunction Drugs Basic Information List
Table Bayer Erectile Dysfunction Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Bayer Erectile Dysfunction Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Bayer Erectile Dysfunction Drugs Sales Market Share (%) in China (2013-2018)
Figure Bayer Erectile Dysfunction Drugs Revenue Market Share (%) in China (2013-2018)
Table Johnson & Johnson Erectile Dysfunction Drugs Basic Information List
Table Johnson & Johnson Erectile Dysfunction Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Johnson & Johnson Erectile Dysfunction Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Johnson & Johnson Erectile Dysfunction Drugs Sales Market Share (%) in China (2013-2018)
Figure Johnson & Johnson Erectile Dysfunction Drugs Revenue Market Share (%) in China (2013-2018)
Table Apricus Biosciences Erectile Dysfunction Drugs Basic Information List
Table Apricus Biosciences Erectile Dysfunction Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Apricus Biosciences Erectile Dysfunction Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Apricus Biosciences Erectile Dysfunction Drugs Sales Market Share (%) in China (2013-2018)
Figure Apricus Biosciences Erectile Dysfunction Drugs Revenue Market Share (%) in China (2013-2018)
Table Dong-A Pharmaceutical Erectile Dysfunction Drugs Basic Information List
Table Dong-A Pharmaceutical Erectile Dysfunction Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Dong-A Pharmaceutical Erectile Dysfunction Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Dong-A Pharmaceutical Erectile Dysfunction Drugs Sales Market Share (%) in China (2013-2018)
Figure Dong-A Pharmaceutical Erectile Dysfunction Drugs Revenue Market Share (%) in China (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Erectile Dysfunction Drugs
Figure Manufacturing Process Analysis of Erectile Dysfunction Drugs
Figure Erectile Dysfunction Drugs Industrial Chain Analysis
Table Raw Materials Sources of Erectile Dysfunction Drugs Major Players/Manufacturers in 2017
Table Major Buyers of Erectile Dysfunction Drugs
Table Distributors/Traders List
Figure China Erectile Dysfunction Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure China Erectile Dysfunction Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Erectile Dysfunction Drugs Price (USD/Unit) Trend Forecast (2018-2025)
Table China Erectile Dysfunction Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure China Erectile Dysfunction Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure China Erectile Dysfunction Drugs Sales Volume Market Share Forecast by Type in 2025
Table China Erectile Dysfunction Drugs Sales (K Units) Forecast by Application (2018-2025)
Figure China Erectile Dysfunction Drugs Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Erectile Dysfunction Drugs Sales Volume Market Share Forecast by Application in 2025
Table China Erectile Dysfunction Drugs Sales (K Units) Forecast by Regions (2018-2025)
Table China Erectile Dysfunction Drugs Sales Volume Share Forecast by Regions (2018-2025)
Figure China Erectile Dysfunction Drugs Sales Volume Share Forecast by Regions (2018-2025)
Figure China Erectile Dysfunction Drugs Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories